Karpman D - Search Results

1

Platelet activation in hemolytic uremic syndrome.

Karpman D, Manea M, Vaziri-Sani F, Ståhl AL, Kristoffersson AC. Karpman D, et al. Semin Thromb Hemost. 2006 Mar;32(2):128-45. doi: 10.1055/s-2006-939769. Semin Thromb Hemost. 2006. PMID: 16575688 Review.

2

Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.

Karpman D, Andreasson A, Thysell H, Kaplan BS, Svanborg C. Karpman D, et al. Pediatr Nephrol. 1995 Dec;9(6):694-9. doi: 10.1007/BF00868714. Pediatr Nephrol. 1995. PMID: 8747107 Clinical Trial.

3

Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura.

Karpman D, Holmberg L, Jirgård L, Lethagen S. Karpman D, et al. Kidney Int. 1996 Jan;49(1):190-9. doi: 10.1038/ki.1996.26. Kidney Int. 1996. PMID: 8770967 Free article.

4

Recurrent mutation Asn45-->Ser of glycoprotein IX in Bernard-Soulier syndrome.

Donnér M, Karpman D, Kristoffersson AC, Winqvist I, Holmberg L. Donnér M, et al. Among authors: karpman d. Eur J Haematol. 1996 Aug;57(2):178-9. doi: 10.1111/j.1600-0609.1996.tb01357.x. Eur J Haematol. 1996. PMID: 8856096 Review. No abstract available.

5

von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura.

Karpman D, Lethagen S, Kristoffersson A, Isaksson C, Holmberg L. Karpman D, et al. Thromb Haemost. 1997 Dec;78(6):1456-62. Thromb Haemost. 1997. PMID: 9423794

6

Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies.

Karpman D, Håkansson A, Perez MT, Isaksson C, Carlemalm E, Caprioli A, Svanborg C. Karpman D, et al. Infect Immun. 1998 Feb;66(2):636-44. doi: 10.1128/IAI.66.2.636-644.1998. Infect Immun. 1998. PMID: 9453620 Free PMC article.

7

Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand's disease.

Holmberg L, Karpman D, Isaksson C, Kristoffersson AC, Lethagen S, Schneppenheim R. Holmberg L, et al. Among authors: karpman d. Thromb Haemost. 1998 Apr;79(4):718-22. Thromb Haemost. 1998. PMID: 9569179

8

Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome.

Karpman D, Papadopoulou D, Nilsson K, Sjögren AC, Mikaelsson C, Lethagen S. Karpman D, et al. Blood. 2001 May 15;97(10):3100-8. doi: 10.1182/blood.v97.10.3100. Blood. 2001. PMID: 11342436 Free article.

9

Enzyme-linked immunosorbent assay for detection of Shiga toxin-producing Escherichia coli infection by antibodies to Escherichia coli secreted protein B in children with hemolytic uremic syndrome.

Sjögren AC, Kaper JB, Caprioli A, Karpman D. Sjögren AC, et al. Among authors: karpman d. Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):208-11. doi: 10.1007/s10096-003-1090-4. Epub 2004 Feb 19. Eur J Clin Microbiol Infect Dis. 2004. PMID: 14986162

10

Factor H binds to washed human platelets.

Vaziri-Sani F, Hellwage J, Zipfel PF, Sjöholm AG, Iancu R, Karpman D. Vaziri-Sani F, et al. Among authors: karpman d. J Thromb Haemost. 2005 Jan;3(1):154-62. doi: 10.1111/j.1538-7836.2004.01010.x. J Thromb Haemost. 2005. PMID: 15634279 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters